Optimizing Subcutaneous Therapy: Key Considerations and Collaborative Opportunities

Administering large-volume injections can pose ergonomic challenges for nurses, especially in situations that require maintaining positions for extended periods, thus increasing physical strain.

Operationally, the increased patient flow enabled by faster SC administration requires adjustment in scheduling, staffing, and documentation practices, particularly in high-volume clinics.

Regardless of the challenges, as more SC formulations gain FDA approval, the appeal to both patients and providers will continue to grow.

NCODA’s Role in Bridging Gaps: Nursing Expertise at the Forefront

To address these challenges and support best practices, NCODA has convened a working group of 11 oncology nursing subject matter experts from diverse practice settings across the country. This group has conducted a comprehensive survey to identify current practice gaps, with the most cited need being enhanced nursing education on SC administration techniques tailored to various medications. Nurses reported relying heavily on manufacturer’s sales representatives and clinical educators, underscoring the need for robust, standardized, and nurse-accessible resources. The formation and engagement of this group affirms the critical role of nursing voices in shaping sustainable, sponsor-supported implementation strategies.

Looking Ahead: Partnering for Progress

The subcutaneous subject matter experts are eager to continue advancing SC therapy delivery through focused collaboration with NCODA’s partners. Opportunities for collaboration include partnering on:

• Clinical roundtable discussionsto share perspectives on practical challenges and approaches to SC administration in different practice settings.
• Focused feedback groupsto help shape nurse-centered education tools that reflect day-to-day realities.
• Development of educational materialsdesigned to support nurses at the point of care—such as guidance on administration techniques or workflow adaptations.
• Resources to improve operational support, including documentation practices, staffing considerations, and resource allocation for SC delivery.
• By supporting these initiatives, NCODA partners can help advance optimal therapy delivery while fostering collaboration with leading oncology practices.Together, we can close knowledge gaps, empower oncology nurses, and ensure that SC therapies reach their full potential in improving patient care.